This is an INDEPENDENT website developed by long-time Emmy Award-winning Journalist Kym McNicholas.

This site is NOT in any way associated or affiliated with Ra Medical Systems or its DABRA Laser System

It depicts my journey following what I believe is a breakthrough medical device from FDA Clearance to commercialization to IPO...and beyond.

Doctors Interviewed

Athar Ansari, MD

California Heart & Vascular Clinic
El Centro, CA

Dr. Athar Ansari has performed more than 150 cases using the DABRA Laser System. He was a part of the FDA study and continued to use the system afterwards.
 
Disclosure: 
Never a shareholder. Never any financial interest. Never a consultant.

Name

Question

Elias Kassab, MD

Beaumont Health
Dearborn, MI

Disclosure: 
Shareholder and consultant.

Name

Question

Ernesto Rodriguera

Excel Medical Center
Tijuana, Mexico

Dr. Rodriguera has performed 27 cases as part of the FDA study for the DABRA Laser System.
 
Disclosure: 
Never a shareholder. Never any financial interest. Never a consultant.

Name

Question

Nitish Choksi

Cardiology & Vascular Associates PC
Dearborn, MI

Disclosure: 
Shareholder. Never a consultant.

Name

Question

Ashok Kondur, MD

Michigan Outpatient Vascular Institute
Dearborn, Michigan

Disclosure:
Shareholder and consultant

Name

Message

Ehtisham Mahumd, MD

UCSD's Chief of Cardiovascular Medicine

Dr. Mahmud performed the very first in-human procedure with the DABRA Laser System. He was Lead Investigator for the FDA Study.
 
Disclosure: 
Never a shareholder. Never any financial interest. Never a consultant.

Name

Question

Mitul Patel, MD

UCSD Health System

Dr. Patel participated in the FDA Study.
 
Disclosure: 
Never a shareholder. Never any financial interest. Never a consultant.

Name

Question

Karl Zhang, MD

Excelsior Integrated Medical Group
Brooklyn, NY

Disclosure: 
Never a shareholder. Never any financial interest. Never a consultant.

Name

Question

Arash Padidar, MD

Minimally Invasive Surgical Solutions
San Jose, California

Disclosure: 
Never a shareholder. Never any financial interest. Never a consultant.

Name

Question

Raghotham Patlola, MD

Wesley Merit Health
Hattiesburg, Mississippi

Dr. Patlola participated in the FDA study.
 
Disclosure: 
Never a shareholder. Has become a consultant.

Name

Message

Doctors Interviewed

Athar Ansari, MD

California Heart & Vascular ClinicEl Centro, CA

Elias Kassab, MD

Beaumont HealthDearborn, MI

Ernesto Rodriguera

Excel Medical CenterTijuana, Mexico

Nitish Choksi

Cardiology & Vascular Associates PCDearborn, MI

Ashok Kondur, MD

Michigan Outpatient Vascular InstituteDearborn, Michigan

Ehtisham Mahumd, MD

UCSD's Chief of Cardiovascular Medicine

Mitul Patel, MD

UCSD Health System

Karl Zhang, MD

Excelsior Integrated Medical GroupBrooklyn, NY

Arash Padidar, MD

Minimally Invasive Surgical SolutionsSan Jose, California

Raghotham Patlola, MD

Wesley Merit HealthHattiesburg, Mississippi

California Heart & Vascular Clinic
El Centro, CA

Beaumont Health
Dearborn, MI

Excel Medical Center
Tijuana, Mexico

Cardiology & Vascular Associates PC
Dearborn, MI

Michigan Outpatient Vascular Institute
Dearborn, Michigan

Excelsior Integrated Medical Group
Brooklyn, NY

Minimally Invasive Surgical Solutions
San Jose, California

Wesley Merit Health
Hattiesburg, Mississippi